![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/08/01/2922906/0/en/Elevar-Therapeutics-Granted-Orphan-Medicinal-Product-Designation-by-the-European-Medicines-Agency-for-First-Line-Systemic-Therapy-for-Unresectable-Hepatocellular-Carcinoma.html
https://www.fiercepharma.com/pharma/elevar-hengrui-eye-quick-refile-pd-1-liver-cancer-combo-after-surprise-fda-rejection
https://www.globenewswire.com/en/news-release/2024/07/09/2910288/0/en/Elevar-Therapeutics-Reports-Plans-for-Near-Term-Resubmission-of-NDA-for-First-Line-Treatment-Option-for-Unresectable-Hepatocellular-Carcinoma-Following-Type-A-FDA-Meeting.html
https://www.globenewswire.com/news-release/2024/05/30/2890629/0/en/Elevar-Therapeutics-Reports-Landmark-Median-Overall-Survival-of-23-8-Months-in-First-Line-Treatment-for-Unresectable-Hepatocellular-Carcinoma.html
https://www.fiercepharma.com/pharma/fda-pd-1-combo-elevar-hengrui-camrelizumab-liver-cancer
https://www.globenewswire.com//news-release/2024/01/18/2811566/0/en/Elevar-Therapeutics-To-Present-Two-Posters-From-Phase-3-CARES-310-Study-at-2024-ASCO-Gastrointestinal-Cancers-Symposium.html
https://www.globenewswire.com//news-release/2023/10/23/2764745/0/en/Elevar-Therapeutics-Names-Brian-Cunningham-Vice-President-of-Sales-and-Kenneth-Rankin-Vice-President-of-Market-Access-Strengthening-Commercial-Leadership-in-Buildup-to-Launch.html
https://www.fiercepharma.com/pharma/elevar-ponies-600m-take-hengruis-investigational-liver-cancer-cocktail-market-us-and-beyond
https://www.globenewswire.com//news-release/2023/10/17/2761595/0/en/Jiangsu-Hengrui-Pharma-and-Elevar-Therapeutics-Announce-Global-Commercialization-Licensing-Agreement-for-PD-1-Inhibitor-Camrelizumab-in-Combination-with-Rivoceranib-for-uHCC.html
https://www.globenewswire.com//news-release/2023/09/21/2747337/0/en/Elevar-Therapeutics-to-Present-at-Cantor-Fitzgerald-Global-Healthcare-Conference.html